Lili Shen, Mulong Du, Chun Wang, Dongying Gu, Meilin Wang, Qi Zhang, Tingting Zhao, Xunlei Zhang, Yongfei Tan, Xinying Huo, Weida Gong, Zhi Xu, Jinfei Chen, Zhengdong Zhang
International journal of molecular sciences 2014 Jul 18This study aimed to investigate the association between POU class5 homeobox 1 pseudogene 1 gene (POU5F1P1) rs10505477 polymorphism and the prognosis of Chinese gastric cancer patients, who received cisplatin-based chemotherapy after surgical resection. POU5F1P1 rs10505477 was genotyped using the SNaPshot method in 944 gastric cancer patients who received gastrectomy. The association of rs10505477 G>A polymorphism with the progression and prognosis in gastric cancer patients was statistically analyzed using the SPSS version 18.0 for Windows. The results reveal that rs10505477 polymorphism has a negatively effect on the overall survival of gastric cancer patients in cisplatin-based chemotherapy subgroup (HR=1.764, 95% CI=1.069-2.911, p=0.023). Our preliminary study indicates for the first time that POU5F1P1 rs10505477 is correlated with survival of gastric cancer patients who receving cisplatin-based chemotherapy after gastrectomy. Further studies are warranted to investigate the mechanism and to verify our results in different populations.
Lili Shen, Mulong Du, Chun Wang, Dongying Gu, Meilin Wang, Qi Zhang, Tingting Zhao, Xunlei Zhang, Yongfei Tan, Xinying Huo, Weida Gong, Zhi Xu, Jinfei Chen, Zhengdong Zhang. Clinical significance of POU5F1P1 rs10505477 polymorphism in Chinese gastric cancer patients receving cisplatin-based chemotherapy after surgical resection. International journal of molecular sciences. 2014 Jul 18;15(7):12764-77
PMID: 25046748
View Full Text